Studies on α-glucosidase, aldose reductase and glycation inhibitory properties of sesquiterpenes and flavonoids of Zingiber zerumbet Smith

Natural Product Research

Volumn 29, Issue 10, 2015, Pages 947-952

  Ajish, K R ^a   Antu, K A ^b   Riya, M P ^b   Preetharani, M R ^b   Raghu, K G ^b   Dhanya, B P ^a   Radhakrishnan, K V ^a  

^a Chemical Sciences and Technology Division CSIR National Institute for Inderdisciplinary Science and Technology   (India)

^b REGIONAL RESEARCH LABORATORY CSIR   (India)

Author keywords

aldose reductase enzyme; anti glycation reaction; zerumbone; Zingiber zerumbet Smith; glucosidase enzyme

Indexed keywords

3",4" O DIACETYLAFZELIN; ACARBOSE; AFZELIN; ALDEHYDE REDUCTASE; ALDOSE REDUCTASE INHIBITOR; ALPHA GLUCOSIDASE; ALPHA GLUCOSIDASE INHIBITOR; FLAVONOID; HUMULENE; ISOKAEMPFERIDE; KAEMPFEROL; KAEMPFEROL 3 O (3,4 DI O ACETYL ALPHA LEVO RHAMNOPYRANOSIDE); SESQUITERPENE DERIVATIVE; UNCLASSIFIED DRUG; ZERUMBONE; ZOPOLRESTAT; ENZYME INHIBITOR; GLYCOSIDASE INHIBITOR; KAEMPFEROL DERIVATIVE; SESQUITERPENE;

ARTICLE; COLUMN CHROMATOGRAPHY; DRUG SCREENING; ENZYME GLYCOSYLATION; ENZYME INHIBITION; ENZYME INHIBITION ASSAY; IC50; IN VITRO STUDY; NUCLEAR MAGNETIC RESONANCE; ZINGIBER ZERUMBET; ANTAGONISTS AND INHIBITORS; CHEMICAL STRUCTURE; CHEMISTRY; ISOLATION AND PURIFICATION; ZINGIBERACEAE;

ZINGIBER ZERUMBET;

ALDEHYDE REDUCTASE; ENZYME INHIBITORS; FLAVONOIDS; GLYCOSIDE HYDROLASE INHIBITORS; KAEMPFEROLS; MOLECULAR STRUCTURE; SESQUITERPENES; ZINGIBERACEAE;

EID: 84928686172     PISSN: 14786419     EISSN: 14786427     Source Type: Journal    
DOI: 10.1080/14786419.2014.956741     Document Type: Article

References (41)

1. Abdelwahab SI, Abdul AB, Mohan S, Taha MM, Syam S, Ibrahim MY, Mariod AA. 2011. Zerumbone induces apoptosis in T-acute lymphoblastic leukemia cells. Leuk Res. 35:268-271.
2. Abdelwahab SI, Abdul AB, Zain ZN, Hadi AH. 2012. Zerumbone inhibits interleukin-6 and induces apoptosis and cell cycle arrest in ovarian and cervical cancer cells. Int Immunopharmacol. 12:594-602.
3. Aggarwal BB, Ajaikumar BK, Harikumar KB, Sheeja TT, Sung B, Anand P. 2008. Potential of spice-derived phytochemicals for cancer prevention. Planta Med. 74:1560-1569 and references therein.
4. Ahmed N. 2005. Advanced glycation end products: role in pathology of diabetic complications. Diabetes Res Clin Pract. 67:3-21.
5. Apostolidis E, Kwon YI, Shetty K. 2007. Inhibitory potential of herb, fruit, and fungal-enriched cheese against key enzymes linked to type 2 diabetes and hypertension. Innov Food Sci Emerg Technol. 8:46-54.
6. Baby S, Dan M, Thaha ARM, Johnson AJ, Kurup R, Balakrishnapillai P, Lim CK. 2009. High content of zerumbone in volatile oils of Zingiber zerumbet from southern India and Malaysia. Flavour Fragr J. 24:301-308.
7. Chung SS, Ho EC, Lam KS, Chung SK. 2003. Contribution of polyol pathway to diabetes-induced oxidative stress. J Am Soc Nephrol. 14:S233-S236.
8. Chung SSM, Chung SK. 2005. Aldose reductase in diabetic microvascular complications. Curr Drug Targets. 6:475-486.
9. Chung SY, Jang DS, Han A-R, Jang JO, Kwon Y, Seo E-K, Lee HJ. 2007. Modulation of P-glycoprotein-mediated resistance by kaempferol derivatives isolated from Zingiber zerumbet. Phytother Res. 21:565-569.
10. Dai JR, Cardellina JH, McMahon JB, Boyd MR. 1997. Zerumbone, an HIV-inhibitory and cytotoxic sesquiterpene of Zingiber aromaticum and Z. zerumbet. Nat Prod Lett. 10:115-118.
11. Damodaran NP, Dev S. 1965. Stereochemistry of zerumbone. Tetrahedron Lett. 24:1977-1981.
12. Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, Lin JK, Farzadfar F, Khang YH, Stevens GA, et al. 2011. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet. 378:31-40.
13. Dev S. 1960. Studies in sesquiterpenes-xvi zerumbone, a monocyclic sesquiterpene ketone. Tetrahedron. 8:171-180.
14. Gabbay KH. 1973. The sorbitol pathway and the complications of diabetes. N Engl J Med. 288:831-836.
15. Goldin A, Beckman JA, Schmidt AM, Creager MA. 2006. Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation. 114:597-605.
16. Huang GC, Chien TY, Chen LG, Wang CC. 2005. Antitumor effects of zerumbone from Zingiber zerumbet in P-388D 1 cells in vitro and in vivo. Plant Med. 71:219-224.
17. Jang DS, Han A-R, Park G, Jhon G-J, Seo E-K. 2004. Flavonoids and aromatic compounds from the rhizomes of Zingiber zerumbet. Arch Pharm Res. 27:386-389.
18. Jianbo X, Guoyin K, Koichiro Y, Xiaoqing C. 2013. Advance in dietary polyphenols as a-glucosidases inhibitors: a review on structure-activity relationship aspect. Crit Rev Food Sci Nutr. 53:818-836.
19. Kader MG, Habib MR, Nikkon F, Yeasmin T, Rashid MA, Rahman MM, Gibbons S. 2009. Zederone from the rhizomes of Zingiber zerumbet and its antistaphylococcal Activity. Bol Latinoam Caribe Plant Med Aromat. 9:63-68.
20. Kashyap SR, Defronzo RA. 2007. The Insulin resistance syndrome: physiological considerations. Diab Vasc Dis Res. 4:13-19.
21. Kirana C, McIntosh GH, Record IR, Jones GP. 2003. Antitumor activity of extract of Zingiber aromaticum and its bioactive sesquiterpenoid zerumbone. Nutr Cancer. 45:218-225.
22. Kitayama T, Okamoto T, Hill RK, Kawai Y, Takahashi S, Yonemori S, Yamamoto Y, Ohe K, Uemura S, Sawada S. 1999. Chemistry of zerumbone. 1. Simplified isolation, conjugate addition reactions, and a unique ring contracting transannular reaction of its dibromide. J Org Chem. 64:2667-2672.
23. Masuda T, Jitoe A, Kato S, Nakatani N. 1991. Acetylated flavonoid glycosides from Zingiber zerumbet. Phytochemistry. 30:2391-2392.
24. Murakami A, Miyamoto M, Ohigashi H. 2004. Zerumbone, an anti-inflammatory phytochemical, induces expression of proinflammatory cytokine genes in human colon adenocarcinoma cell lines. Biofactor. 21:95-101.
25. Murakami A, Ohigashi H. 2007. Targeting NOX, INOS and COX-2 in inflammatory cells: chemoprevention using food phytochemicals. Int J Cancer. 121:2357-2363.
26. Murakami A, Tanaka T, Lee JY, Surh YJ, Kim HW, Kawabata K, Nakamura Y, Jiwajinda S, Ohigashi H. 2004. Zerumbone, a sesquiterpene in subtropical ginger, suppresses skin tumor initiation and promotion stages in ICR mice. Int J Cancer. 110:481-490.
27. Nakatani N, Jitoe A, Masuda T, Yonemori S. 1991. Flavonoid constituents of Zingiber zerumbet Smith. Agric Biol Chem. 55:455-460.
28. Neuenschwander U, Czarniecki B, Hermans I. 2012. Origin of regioselectivity in a-humulene functionalization. J Org Chem. 77:2865-2869.
29. Osonoi T, Saito M, Mochizuki K, Fukaya N, Muramatsu T, Inoue S, Fuchigami M, Goda T. 2010. The a-glucosidase inhibitor miglitol decreases glucose fluctuations and inflammatory cytokine gene expression in peripheral leukocytes of Japanese patients with type 2 diabetes mellitus. Metabolism. 59:1816-1822.
30. Ozaki Y, Kawahara N, Harada M. 1991. Anti-inflammatory effect of Zingiber cassumunar Roxb and its active principles. Chem Pharm Bull. 39:2353-2356.
31. Prakash RO, Rabinarayan A, Kumar MS. 2011. Zingiber zerumbet (L.) Sm., a reservoir plant for therapeutic uses: a review. Int J Pharma World Res. 2:1-23.
32. Priya RM, Padmakumari KP, Sankarikutty B, Lijocheriyan O, Nisha VM, Raghu KG. 2011. Inhibitory potential of ginger extracts against enzymes linked to type 2 diabetes, inflammation and induced oxidative stress. Int J Food Sci Nutr. 62:106-110.
33. Riya MP, Antu KA, Vinu T, Chandrakanth KC, Anilkumar KS, Raghu KG. 2013. doi:10.1002/jsfa.6340 An in vitro study reveals nutraceutical properties of Ananas comosus (L.) Merr. var. Mauritius residue beneficial to diabetes. J Sci Food Agric.
34. Singh CB, Nongalleima Kh, Brojendrosingh S, Ningombam S, Lokendrajit N, Singh LW. 2012. Biological and chemical properties of Zingiber zerumbet Smith: a review. Phytochem Rev. 11:113-125.
35. Sulaiman MR, Perimal EK, Akhtar MN, Mohamad AS, Khalid MH, Tasrip NA, Mokhtar F, Zakaria ZA, Lajis NH, Israf DA. 2010. Anti-inflammatory effect of zerumbone on acute and chronic inflammation models in mice. Fitoterapia. 81:855-858.
36. Sung B, Prasad S, Yadav VR, Aggarwal BB. 2012. Cancer cell signaling pathways targeted by spice-derived nutraceuticals. Nutr Cancer. 64:173-197.
37. Szabolcs A, Tiszlavicz L, Kaszaki J, Pósa A, Berkó A, Varga IS, Boros I, Szüts V, Lonovics J, Takács T. 2007. Zerumbone exerts a beneficial effect on inflammatory parameters of cholecystokinin octapeptide-induced experimental pancreatitis but fails to improve histology. Pancreas. 35:249-255.
38. Taha MM, Abdul AB, Abdullah R, Ibrahim TA, Abdelwahab SI, Mohan S. 2010. Potential chemoprevention of diethylnitrosamine-initiated and 2-acetylaminofluorene-promoted hepatocarcinogenesis by zerumbone from the rhizomes of the subtropical ginger (Zingiber zerumbet). Chem Biol Interact. 186:295-305.
39. Tzeng TF, Liou SS, Chang CJ, Liu IM. 2013a. The ethanol extract of Zingiber zerumbet attenuates streptozotocin-induced diabetic nephropathy in rats. Evid Based Complement Alternat Med. 2013:340645.
40. Tzeng TF, Liou SS, Chang CJ, Liu IM. 2013b. Zerumbone, a tropical ginger sesquiterpene, ameliorates streptozotocin induced diabetic nephropathy in rats by reducing the hyperglycemia induced inflammatory response. Nutr Metab (Lond). 10:64/1-64/12.
41. Vasan S, Foiles PG, Founds HW. 2001. Therapeutic potential of AGE inhibitors and breakers of AGE protein cross-links. Exp Opin Invest Drugs. 10:1977-1987.